Company Profile LogoMirum Pharmaceuticals

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

Edit IconSuggest an Edit
Pharmaceutical
Biotechnology
Health Care
Therapeutics

    Unlock insights on Mirum Pharmaceuticals and 2M+ companies now!

    About Mirum Pharmaceuticals

    Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

    Top 100 in Pharmaceutical in United States
    Top 100 in Therapeutics in United States
    Company Highlights
    Year Founded

    2018

    icon-altEmployees

    324

    Location (HQ)

    USA

    Since Last Funding

    1 year 5 months

    Monthly Website Visitors

    4.9K

    icon-altTotal Investment Amt

    $500M

    Last Funding Round

    Post Ipo Equity

    icon-altMoM Headcount Growth

    0.31%

    icon-altYoY Headcount Growth

    39.04%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Therapeutics

    Health Care

    Biotechnology

    Pharmaceutical

    Pharmaceutical Manufacturing

    Pharmaceuticals